Terms: = Leukemia AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Diagnosis
17 results:
1. Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis.
Moreno-Castaño AB; Fernández S; Ventosa H; Palomo M; Martinez-Sanchez J; Ramos A; Ortiz-Maldonado V; Delgado J; Fernández de Larrea C; Urbano-Ispizua A; Penack O; Nicolás JM; Téllez A; Escolar G; Carreras E; Fernández-Avilés F; Castro P; Diaz-Ricart M
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37045474
[TBL] [Abstract] [Full Text] [Related]
2. pai-1 and protein C as early markers of veno-occlusive disease in patients treated for Wilms tumor.
Cesaro S; Mauro M; Sattin G; Sartori MT; Saggiorato G; Paratella A; Tridello G; Bisogno G
Pediatr Blood Cancer; 2019 Jul; 66(7):e27695. PubMed ID: 30865371
[TBL] [Abstract] [Full Text] [Related]
3. Endothelial Function in Children with Acute Lymphoblastic leukemia (ALL) May Reflect the Clinical Outcome.
Doroszko A; Niedzielska E; Jakubowski M; Porwolik J; Turek-Jakubowska A; Szahidewicz-Krupska E; Sieczkowski B; Dobrowolski P; Radziwon A; Skomro R; Derkacz A; Mazur G; Chybicka A; Szuba A
Biomed Res Int; 2018; 2018():7918091. PubMed ID: 30534565
[TBL] [Abstract] [Full Text] [Related]
4. Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1.
Mauro M; Saggiorato G; Sartori MT; Gallo G; De Bortoli M; Bonetti E; Zaccaron A; Vitale V; Balter R; Chinello M; Cesaro S
Pediatr Blood Cancer; 2018 Jun; 65(6):e26963. PubMed ID: 29350496
[TBL] [Abstract] [Full Text] [Related]
5. Coagulation profile during induction chemotherapy in childhood acute lymphoblastic leukemia.
Sehgal S; Sharma S; Chandra J; Nangia A
Indian J Pathol Microbiol; 2017; 60(1):50-56. PubMed ID: 28195091
[TBL] [Abstract] [Full Text] [Related]
6. [Impaired endometrial receptivity in primary infertility in women with undifferentiated connective tissue dysplasia and hereditary thrombophilia].
Zanozin AS; Demura TA; Kolosovsky DY; Faizullina NM; Kogan EA
Arkh Patol; 2016; 78(6):23-29. PubMed ID: 28139599
[TBL] [Abstract] [Full Text] [Related]
7. Coagulation Profile at diagnosis in Patients with Acute Lymphoblastic leukemia.
Sehgal S; Sharma S; Chandra J; Nangia A
Indian J Pediatr; 2016 Oct; 83(10):1082-6. PubMed ID: 27109393
[TBL] [Abstract] [Full Text] [Related]
8. Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia.
Järvelä LS; Niinikoski H; Lähteenmäki PM; Heinonen OJ; Kapanen J; Arola M; Kemppainen J
J Cancer Surviv; 2010 Dec; 4(4):339-45. PubMed ID: 20552291
[TBL] [Abstract] [Full Text] [Related]
9. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
Giordano P; Molinari AC; Del Vecchio GC; Saracco P; Russo G; Altomare M; Perutelli P; Crescenzio N; Santoro N; Marchetti M; De Mattia D; Falanga A
Am J Hematol; 2010 May; 85(5):325-30. PubMed ID: 20425794
[TBL] [Abstract] [Full Text] [Related]
10. [Usefulness of serum plasminogen activator inhibitor-1 for diagnosis and monitoring of late-onset sinusoidal obstruction syndrome after allogeneic stem cell transplantation].
Ito S; Taguchi J; Kato J; Nakaya A; Tachibana T; Takemura S; Sano A; Ohata M; Ishigatsubo Y; Fujita H
Rinsho Ketsueki; 2010 Jan; 51(1):69-73. PubMed ID: 20134143
[TBL] [Abstract] [Full Text] [Related]
11. The relation between plasminogen activator inhibitor activity and disease activation in acute myeloblastic leukaemia patients.
Yilmaz M; Dagdas S; Aki SZ; Guler N; Akoz AG; Erdin Z; Alanoglu G; Ozet G
Clin Lab Haematol; 2006 Oct; 28(5):313-6. PubMed ID: 16999721
[TBL] [Abstract] [Full Text] [Related]
12. Thrombosis in children with acute lymphoblastic leukemia. Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy.
Athale UH; Chan AK
Thromb Res; 2003; 111(4-5):199-212. PubMed ID: 14693164
[TBL] [Abstract] [Full Text] [Related]
13. Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide.
Lee JH; Lee KH; Lee JH; Kim S; Seol M; Park CJ; Chi HS; Kang W; Kim ST; Kim WK; Lee JS
Br J Haematol; 2002 Sep; 118(4):1087-94. PubMed ID: 12199790
[TBL] [Abstract] [Full Text] [Related]
14. [Hemostatic variations associated with acute leukemia: clinical and prognostic significance].
Zhao W; Wang X; Qu B; Hu J; Sheng Z; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):469-71. PubMed ID: 11877021
[TBL] [Abstract] [Full Text] [Related]
15. Plasma levels of total plasminogen activator inhibitor-I (pai-I) and tPA/pai-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract] [Full Text] [Related]
16. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia.
Zhao W; Wang H; Wang X; Wu F; Guo W; Qu B; Shen Z; Wang Z
Thromb Res; 2001 May; 102(3):197-204. PubMed ID: 11369412
[TBL] [Abstract] [Full Text] [Related]
17. [Hemostasis in patients with acute leukemia treated with high doses of cytosine-arabinoside: the effect of chemotherapy and infectious complications on hemostasis].
Cetkovský P; Koza V; Cepelák V; Vít L
Vnitr Lek; 1994 Nov; 40(11):730-4. PubMed ID: 7810098
[TBL] [Abstract] [Full Text] [Related]
